Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 14.62B P/E 27.39 EPS this Y -20.20% Ern Qtrly Grth 41.30%
Income 3.68B Forward P/E 27.25 EPS next Y 24.70% 50D Avg Chg -
Sales 17.55B PEG -1,277.67 EPS past 5Y 7.96% 200D Avg Chg -7.00%
Dividend 11.00% Price/Book 1.06 EPS next 5Y -0.18% 52W High Chg -26.00%
Recommedations 3.50 Quick Ratio 0.75 Shares Outstanding 276.60M 52W Low Chg 15.00%
Insider Own - ROA 10.62% Shares Float 204.58M Beta 0.41
Inst Own 0.05% ROE 27.89% Shares Shorted/Prior -/- Price 52.86
Gross Margin 54.64% Profit Margin 20.94% Avg. Volume 27,390 Target Price 51.23
Oper. Margin 25.53% Earnings Date - Volume 17,297 Change 0.95%
About NOVOZYMES A/S UNSP ADR EACH REP

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America. The company offers baking, beverages, dairy, starch, and protein solutions for the food and beverage industry; laundry, dishwashing, and professional cleaning solutions for the household care industry; agriculture solutions, including crop production, and animal health and nutrition solutions; bioyield and biocontrol solutions for crops; and grain and technical processing solutions, as well as bio energy solutions for liquefaction, saccharifaction, fermentation, fiber conversion, and biomass conversion. It also provides textile solutions, such as biopreparation, biopolishing, bleach clean-up, denim abrasion and finishing, and desizing solutions. In addition, the company offers solutions for pulp & paper, including fiber modification, bleach boosting, deposit control, starch modification, and deinking; leather solutions comprising acid bating, area expansion, bating, degreasing, soaking, and unhairing and liming; and water and waste management solutions, which consist of bioaugmentation, biogas, and sludge management. Further, it provides pharmaceutical solutions, including lipases, immobilized lipases, and proteases for biocatalysis, as well as rTrypsin for cell culture; and human health and protein solutions. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.

NOVOZYMES A/S UNSP ADR EACH REP News
03:59 AM Invitation to Novozymes' annual shareholders' meeting 2023
01/26/23 Novozymes delivers historically strong full-year results
12/12/22 Novozymes shares slide after merger with rival Chr. Hansen unveiled
12/12/22 Novozymes and Chr. Hansen agree deal to merge
12/12/22 Novozymes and Chr. Hansen to combine and create a leading global biosolutions partner
11/10/22 As one of the first companies in the world, Novozymes has had its net-zero target validated by the Science Based Targets initiative
11/10/22 Novozymes and LinusBio announce collaboration to accelerate scientific discovery in Biohealth
02:00 AM Novozymes confirms upgraded guidance by strong start to Q4
11/01/22 Novozymes Named EPA Safer Choice Partner of the Year for Second Consecutive Year
10/24/22 Biotalys and Novozymes announce successful Evoca™ feasibility study
08/11/22 Edited Transcript of NZYMb.CO earnings conference call or presentation 11-Aug-22 7:00am GMT
08/11/22 Novozymes delivers strong half year results and narrows full-year outlook upwards
07/15/22 Novozymes plan to further increase prices across the portfolio in response to the significant and persistent hike in incoming cost
07/14/22 AXTA vs. NVZMY: Which Stock Is the Better Value Option?
06/20/22 ESI vs. NVZMY: Which Stock Should Value Investors Buy Now?
06/07/22 Novozymes extends the lifetime of textiles with sustainable innovation
05/31/22 ICL vs. NVZMY: Which Stock Is the Better Value Option?
04/26/22 Novozymes delivers strong 2022 Q1 results and raises full-year financial guidance
03/31/22 Novozymes announces plan to increase prices to cover rising cost of raw materials, energy, and logistics